Research programme: casein kinase 2 inhibitors - Kyoto University/Toray/Tokyo Womens Medical University
Alternative Names: Casein kinase 2 inhibitors research programme - Kyoto University/Toray/Tokyo Womens Medical UniversityLatest Information Update: 28 Aug 2007
At a glance
- Originator Kyoto University; Tokyo Medical University; Toray
- Class
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Nephritis
Most Recent Events
- 03 Jun 2005 Preclinical trials in Nephritis in Japan (unspecified route)